310
Views
19
CrossRef citations to date
0
Altmetric
Review

Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013–2019)

ORCID Icon & ORCID Icon
Pages 805-815 | Received 30 Jul 2019, Accepted 04 Sep 2019, Published online: 09 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Samuel T. Boateng, Tithi Roy, Kara Torrey, Uchechi Owunna, Sergette Banang-Mbeumi, David Basnet, Eleonora Niedda, Alexis D. Alexander, Denzel El Hage, Siriki Atchimnaidu, Bolni Marius Nagalo, Dinesh Aryal, Ann Findley, Navindra P. Seeram, Tatiana Efimova, Mario Sechi, Ronald A. Hill, Hang Ma, Jean Christopher Chamcheu & Siva Murru. (2023) Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Francesco Mincione, Alessio Nocentini & Claudiu T. Supuran. (2021) Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opinion on Drug Discovery 16:10, pages 1209-1225.
Read now
Claudiu T. Supuran. (2020) An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 16:4, pages 297-307.
Read now
Zhuang Hou, Chuanchao Li, Yichuang Liu, Miao Zhang, Yitong Wang, Zhanfang Fan, Chun Guo, Bin Lin & Yang Liu. (2020) Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 383-390.
Read now
Claudiu T Supuran. (2019) The management of glaucoma and macular degeneration. Expert Opinion on Therapeutic Patents 29:10, pages 745-747.
Read now

Articles from other publishers (14)

Maria Letizia Salvetat, Francesco Pellegrini, Leopoldo Spadea, Carlo Salati & Marco Zeppieri. (2023) Pharmaceutical Approaches to Normal Tension Glaucoma. Pharmaceuticals 16:8, pages 1172.
Crossref
Christian Platzl, Alexandra Kaser-Eichberger, Heidi Wolfmeier, Andrea Trost & Falk Schroedl. (2023) Human intrinsic choroidal neurons do not alter the expression of intrinsic markers in response to pressure. British Journal of Ophthalmology 107:8, pages 1209-1215.
Crossref
Jia-Heng Zhang, Mei-Juan Wang, Ya-Ting Tan, Jia Luo & Shu-Chao Wang. (2023) A bibliometric analysis of apoptosis in glaucoma. Frontiers in Neuroscience 17.
Crossref
Claudiu T. Supuran. 2023. Nitric Oxide in Health and Disease. Nitric Oxide in Health and Disease 305 317 .
Min Li, Zhao-Lin Gao, Quan-Peng Zhang, Ai-Xiang Luo, Wei-Ye Xu, Tian-Qi Duan, Xu-Peng Wen, Ru-Qi Zhang, Ru Zeng & Ju-Fang Huang. (2022) Autophagy in glaucoma pathogenesis: Therapeutic potential and future perspectives. Frontiers in Cell and Developmental Biology 10.
Crossref
Kun-Che Chang, Pei-Feng Liu, Chia-Hsuan Chang, Ying-Cheng Lin, Yen-Ju Chen & Chih-Wen Shu. (2022) The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases. Cell & Bioscience 12:1.
Crossref
Benas Balandis, Tomas Šimkūnas, Vaida Paketurytė-Latvė, Vilma Michailovienė, Aurelija Mickevičiūtė, Elena Manakova, Saulius Gražulis, Sergey Belyakov, Visvaldas Kairys, Vytautas Mickevičius, Asta Zubrienė & Daumantas Matulis. (2022) Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases. Pharmaceuticals 15:4, pages 477.
Crossref
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Andrea Trost, Karolina Motloch, Andreas Koller, Daniela Bruckner, Christian Runge, Falk Schroedl, Barbara Bogner, Alexandra Kaser-Eichberger, Clemens Strohmaier, Anja-Maria Ladek, Julia Preishuber-Pfluegl, Susanne Maria Brunner, Ludwig Aigner & Herbert Anton Reitsamer. (2021) Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension. Experimental Eye Research 213, pages 108806.
Crossref
Nicoletta Marchesi, Foroogh Fahmideh, Federica Boschi, Alessia Pascale & Annalisa Barbieri. (2021) Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas. Cells 10:9, pages 2394.
Crossref
Claudiu T. Supuran. (2021) Emerging role of carbonic anhydrase inhibitors. Clinical Science 135:10, pages 1233-1249.
Crossref
Smriti Sharma & Vinayak Bhatia. (2021) Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances. Current Topics in Medicinal Chemistry 21:2, pages 115-125.
Crossref
Gloria Cimaglia, Marcela Votruba, James E. Morgan, Helder André & Pete A. Williams. (2020) Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration. Nutrients 12:9, pages 2871.
Crossref
志南 刘. (2020) Progress in the Treatment of Dry Age-Related Macular Degeneration. Advances in Clinical Medicine 10:05, pages 849-855.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.